The Time To Buy Tempus AI Inc (NASDAQ: TEM) Is Now
During the last session, Tempus AI Inc (NASDAQ:TEM)’s traded shares were 10.65 million, with the beta value of the company hitting 5.68. At the end
During the last session, Tempus AI Inc (NASDAQ:TEM)’s traded shares were 10.65 million, with the beta value of the company hitting 5.68. At the end
During the last session, Sagimet Biosciences Inc (NASDAQ:SGMT)’s traded shares were 1.19 million, with the beta value of the company hitting 2.23. At the end
During the last session, Vera Therapeutics Inc (NASDAQ:VERA)’s traded shares were 1.33 million, with the beta value of the company hitting 1.13. At the end
During the last session, Fuelcell Energy Inc (NASDAQ:FCEL)’s traded shares were 3.52 million, with the beta value of the company hitting 4.11. At the end
During the last session, Microvision Inc (NASDAQ:MVIS)’s traded shares were 7.31 million, with the beta value of the company hitting 1.57. At the end of
During the last session, Quantum Corp (NASDAQ:QMCO)’s traded shares were 1.03 million, with the beta value of the company hitting 2.78. At the end of
During the last session, EchoStar Corp (NASDAQ:SATS)’s traded shares were 3.54 million, with the beta value of the company hitting 0.75. At the end of
During the last session, CureVac N.V (NASDAQ:CVAC)’s traded shares were 1.01 million, with the beta value of the company hitting 2.50. At the end of
During the last session, Vor Biopharma Inc (NASDAQ:VOR)’s traded shares were 1.18 million, with the beta value of the company hitting -0.51. The 52-week high
During the last session, Banzai International Inc (NASDAQ:BNZI)’s traded shares were 1.29 million, with the beta value of the company hitting -0.48. The 52-week high
© 2024, Powered by Smart TechOne